Neuralink’s “Telepathy” gives speech and control back to patients

After the first human implant in early 2024, Neuralink scaled its “Telepathy” brain–computer interface to multiple participants, including people with ALS and severe paralysis. Patients have used it to control computers and phones, play games, and — for those who had lost the ability to speak — communicate again by decoding intended movement or speech directly from the brain.

By 2026 more than 20 people had received implants, all actively using their devices, with the company reporting no serious adverse device events. Restoring autonomy and a voice to people locked out of the world by paralysis is exactly the near-term mission Neuralink set out to achieve.

Each new participant also feeds a virtuous cycle: more implants generate more neural data, which sharpens the decoding algorithms and extends how long the device stays useful. The longer-term roadmap — restoring sight with the Blindsight visual-cortex implant, and eventually higher-bandwidth links — depends on exactly this kind of careful, monitored scaling. Reaching 20-plus patients with no reported serious device events is the evidence that the cautious approach is maturing into a repeatable medical procedure rather than stalling at a single proof-of-concept.